Neurocrine Biosciences (NBIX) Stock Chart & Stock Price History $138.86 -3.06 (-2.16%) As of 12:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Neurocrine Biosciences Stock Price Performance The Neurocrine Biosciences (NBIX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 11.00%, with a year-to-date return of 1.73%. In the past month, the stock has increased 7.72%, reflecting recent market activity. As of the latest close, Neurocrine Biosciences traded at $141.92 with a market cap of $14.08 billion and volume of 786,333 shares. Five years ago, the stock traded at $110.77, representing a 25.36% increase over that period. At the time, it had a market cap of $10.80 billion and a volume of 904,701 shares. Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.53%1 Month Performance+7.72%3 Month Performance+11.09%Year-To-Date Performance+1.73%1 Year Performance+11.00%5 Year Performance+25.36% NBIX Stock Chart for Wednesday, September, 3, 2025 NBIX Chart by TradingView Neurocrine Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/02/2025$139.60$141.92+1.66%$142.91$138.57786,333 shs$14.08 billion09/01/2025$139.60$139.60$140.03$138.08503,700 shs$13.85 billion08/29/2025$138.94$139.60+0.48%$140.03$138.08503,700 shs$13.85 billion08/28/2025$138.13$138.94+0.59%$139.08$137.00449,618 shs$13.78 billion08/27/2025$136.84$138.13+0.94%$139.03$136.94740,926 shs$13.70 billion08/26/2025$133.99$136.84+2.13%$137.14$133.621.11 million shs$13.57 billion08/25/2025$135.43$133.99-1.06%$135.71$133.69530,293 shs$13.29 billion08/22/2025$135.28$135.43+0.11%$137.02$134.31547,980 shs$13.43 billion08/21/2025$133.23$135.28+1.54%$135.63$132.41553,371 shs$13.42 billion08/20/2025$132.81$133.23+0.32%$133.71$131.91518,762 shs$13.21 billion Get the Latest News and Ratings for NBIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. 08/19/2025$133.14$132.81-0.25%$134.78$132.76674,793 shs$13.17 billion08/18/2025$132.90$133.14+0.18%$133.54$132.37585,254 shs$13.20 billion08/15/2025$131.31$132.90+1.21%$133.25$131.20558,515 shs$13.18 billion08/14/2025$131.62$131.31-0.24%$132.11$130.26782,784 shs$13.02 billion08/13/2025$128.89$131.62+2.12%$131.79$129.851.06 million shs$13.05 billion08/12/2025$123.98$128.89+3.96%$129.04$124.36994,359 shs$12.78 billion08/11/2025$125.01$123.98-0.82%$125.91$123.69923,003 shs$12.30 billion08/08/2025$125.60$125.01-0.47%$126.44$123.671.05 million shs$12.40 billion08/07/2025$128.43$125.60-2.20%$129.35$124.791.23 million shs$12.46 billion08/06/2025$128.39$128.43+0.03%$128.53$126.45823,220 shs$12.74 billion08/05/2025$128.04$128.39+0.27%$128.74$126.60862,659 shs$12.73 billion08/04/2025$128.91$128.04-0.67%$128.91$125.371.53 million shs$12.70 billion Related Companies Biogen Stock Chart Incyte Stock Chart United Therapeutics Stock Chart BioMarin Pharmaceutical Stock Chart Exelixis Stock Chart Madrigal Pharmaceuticals Stock Chart Exact Sciences Stock Chart Halozyme Therapeutics Stock Chart Repligen Stock Chart Ionis Pharmaceuticals Stock Chart Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBIX) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBIX Stock Alerts